SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016928
Filing Date
2023-05-15
Accepted
2023-05-15 08:01:02
Documents
86
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1027046
2 ex10-4.htm EX-10.4 51707
3 ex31-1.htm EX-31.1 18988
4 ex31-2.htm EX-31.2 18936
5 ex32-1.htm EX-32.1 6330
6 ex32-2.htm EX-32.2 6422
7 ex10-4_001.jpg GRAPHIC 36959
  Complete submission text file 0001493152-23-016928.txt   5395773

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE vbiv-20230331.xsd EX-101.SCH 46571
9 XBRL CALCULATION FILE vbiv-20230331_cal.xml EX-101.CAL 67299
10 XBRL DEFINITION FILE vbiv-20230331_def.xml EX-101.DEF 167592
11 XBRL LABEL FILE vbiv-20230331_lab.xml EX-101.LAB 344684
12 XBRL PRESENTATION FILE vbiv-20230331_pre.xml EX-101.PRE 279567
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 687632
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 23918499
SIC: 2834 Pharmaceutical Preparations